QuidelOrtho Corporation

Financials

İşletme faaliyetlerinden elde edilen nakit 63.7 M65.6 M-46.8 M-45.5 M131.9 M 105.2 M Yatırım faaliyetlerinden elde edilen nakit -37.9 M-56.2 M-33 M-53.9 M-49.6 M -192.7 M Finansman faaliyetlerinden elde edilen nakit -68.9 M17.6 M103.3 M46 M-11.1 M 155.8 M Free cash flow 16.5 M9.4 M-84.3 M-94.7 M86.6 M -83 M

QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs.

QDEL

Financials

QuidelOrtho Corporation

Haberler

QuidelOrtho (QDEL) Drops 20% After-Hours On Wednesday— What's Going On? - QuidelOrtho (NASDAQ:QDEL)

QuidelOrtho hisseleri zayıf gelir rehberliğiyle çakıldı

UBS, Quidel’in hisse hedefini düşürdü

Quidel Corporation hissesi 14,43 dolarda 52 haftalık dip yaptı

Quidel hissesi 15,03 dolarda 52 haftalık dibe vurdu

QuidelOrtho, Nathaniel Sisitsky’yi hukuk müdürü olarak atadı

Quidel Corporation hissesi 17,07 dolarda 52 haftalık dip yaptı

QuidelOrtho Corporation (QDEL) Presents at 47th Annual Raymond James Institutional Investor Conference - Slideshow (NASDAQ:QDEL) 2026-03-09

Quidel hissesi 19,48 dolarda 52 haftanın dibini gördü

Quidel stock hits 52-week low at 19.48 USD

QuidelOrtho Raymond James Konferansı: Stratejik Büyüme Görünümü

QuidelOrtho at Raymond James Conference: Strategic Growth Insights